{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "355",
                "374"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wrodzon\u0105 wad\u0105 serca"
        },
        {
            "identifier": "T2",
            "position": [
                "451",
                "466"
            ],
            "subtype": "Symptom",
            "type": "T",
            "value": "Stan do\u015b\u0107 dobry"
        },
        {},
        {
            "icd": "ICD10:Q20",
            "identifier": "N1",
            "referenced": "T1",
            "subtype": "Reference",
            "type": "N",
            "value": "Wrodzone wady rozwojowe jam i po\u00c5\u0082\u00c4\u0085cze\u00c5\u0084 sercowych"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 2 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: m\u0119ska\n------------------------------------------------\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nCh\u0142opiec z wrodzon\u0105 wad\u0105 serca przyj\u0119ty do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan do\u015b\u0107 dobry\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nRKZ Parametry krytyczne\n    pH:7.386\n    pCO2:39.4[mmHg]\n    BE:-1.20[mmol/L]\n    HCO3:23.1[mmol/L]\n    pO2:56.0[mmHg]\n    O2Sat:88.9[%]\n    COMMENT_HL7:\nMorfologia\n    WBC:8.77[10\\\\^3/ul]\n    RBC:4.74[10\\\\^6/ul]\n    HGB:12.2[g/dl]\n    HCT:34.4[%]\n    MCV:72.6[fl]\n    MCH:25.7[pg]\n    MCHC:35.5[g/dl]\n    PLT:376.0[10\\\\^3/ul]\n    RDW-SD:36.1[fl]\n    RDW-CV:13.7[%]\n    PDW:10.2[fl]\n    MPV:9.5[fl]\n    P-LCR:20.5[%]\n    PCT:0.4[%]\n    NEUTR#:2.78[10\\\\^3/ul]\n    NEUTR%:31.6[%]\n    LYMPH#:3.50[10\\\\^3/ul]\n    LYMPH%:39.9[%]\n    MONO#:0.98[10\\\\^3/ul]\n    MONO%:11.20[%]\n    EO#:1.47[10\\\\^3/ul]\n    EO%:16.80[%]\n    BASO#:0.04[10\\\\^3/ul]\n    BASO%:0.50[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nImmununochemia -Immulite: COMMENT_HL7:\nD-dimery t. ilo\u015bciowy: D-dimer:272.0[ng/ml]\nFibrynogen (F): FIB:2.39[g/L]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:29.4[s]\nINR: INR:1.0\nCzas protrombinowy (PT): PT:11.1[s]\nCzas trombinowy (TT): TT:17.4[s]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:99[%]\nKreatynina: CREA:0.30[mg/dl]\nMocznik: UREA:18.00[mg/dl]\nASPAT: AST:30.00[IU/L]\nALAT: ALT:29.00[IU/L]\nNT- proBNP: NTpBNP:196.00[pg/ml]\nTSH: TSH:2.69[uIU/ml]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:103.3[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:75[cm]\neGFR (1-13r\u017c M) stand.wg.Schwartza  wsp. 0.550: eGFR 1-13M:137.5[ml/min/1,73m2]\nFT3 III: FT3 III:4.88[pg/ml]\nFT4II: FT4II:1.47[ng/dl]\n------------------------------------------------\nICD10\n------------------------------------------------\nQ25.0\nZ98.8\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\nO69\n89.602\n87.415\nG21\nG25\n87.440\n89.541\n88.761\nL69\n------------------------------------------------"
}